The tech behind the first FDA-approved CAR-T cell therapy
To develop the first-FDA approved CAR-T immunotherapy, Novartis used Thermo Fisher’s proprietary cell therapy systems (CTS) Dynabeads technology.
Archives for October 3, 2017
Immunoprecise ups antibody services with second CRO purchase
Immunoprecise Antibodies is set to purchase QVQ Holding BV in its most recent acquisition that further increases its antibody services.
PETA: ‘Animals for disease research is like marketing carrier pigeons for mass communications’
The People for the Ethical Treatment of Animals (PETA) is looking to send a researcher to learn about non-animal test methods – adoption of which it says is slowed by regulatory agency acceptance.
Mind-altering medicine: psilocybin therapy to combat depression
Compass Pathways is using synthesised psilocybin –an active ingredient in magic mushrooms – to develop therapies for treatment-resistant depression